In a report researchers have revealed that they are developing a test which could recognize if women are at risk of life threatening condition that occurs in pregnancy. Presently there is no method of envisaging pre-ecamplsia, in which blood pressure is increased and can escort to stroke and even death.
The pregnancy condition can also escort to stillbirth, premature birth and baby born with low weight. Pre-eclampsia is typified by high blood pressure and higher level of protein in the urine. Researchers believe that the condition occurs in early pregnancy with faulty growth of the placenta.
But the new study paves the way for a test that could envisage the obstacle that can be lethal for both mother and the baby. The symptoms of the condition do not show up until the second half of the pregnancy and currently there is no cure except delivering the baby.
A sequence of forty-five various composites was detected that were associated with metabolism, dissimilar in the women who went on to develop the condition, found a team of international researchers. The metabolic fingerprint could shape the base of the test.
All they know about the condition proposes that women do not become unwell and present with pre-eclamsia until late in pregnancy, but the condition derives in early pregnancy. For developing effective cure and preventive approach they need to start treatment in early pregnancy, explained study author Professor Louise Kenny from University College Cork, Ireland.
They are hoping to develop a single blood test that will be cheap and readily available to hospitals. In coming years their aim is to develop a single blood test that would be available to all pregnant women who will at risk of pre-eclamsia, explained Phil Baker, co-author of the study from the University of Alberta, in Canada.